Quebec City (Quebec), May 14, 2013 – Atrium Innovations inc. (TSX: ATB) (“Atrium” or the “Company”) announced today that all of the nominees listed in the Management Proxy Circular dated March 28, 2013 were elected as directors of Atrium by a majority of the votes cast by the shareholders present or represented by proxy. The detailed results of the vote for the election of the directors at Atrium’s Annual General Meeting of Shareholders held earlier today in Montreal are set out below.
For
Withold
Number
%
Number
%
Yvon Bolduc
18 888 515
97,76
431 946
2,24
Alain Bouchard
17 686 414
91,54
1 634 048
8,46
Éric Dupont
19 209 248
99,42
111 214
0,58
Pierre Fitzgibbon
18 765 377
97,13
555 085
2,87
Jacques Gauthier
18 818 278
97,40
502 184
2,60
Claude Lamoureux
18 799 402
97,30
521 061
2,70
Pierre Laurin
18 382 170
95,14
938 292
4,86
Gérard Limoges
18 880 842
97,72
439 620
2,28
Javier San Juan
19 230 587
99,53
89 876
0,47
Carole St-Charles
18 710 139
96,84
610 324
3,16
About Atrium Innovations
Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries. The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,100 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available at www.atrium-innovations.com.
Investor Relations:
Mario Paradis
Vice President and Chief Financial Officer
Tel. : (418) 652-1116 [email protected]
Atrium Innovations Announces Election of Directors
Consult the PDF version
Quebec City (Quebec), May 14, 2013 – Atrium Innovations inc. (TSX: ATB) (“Atrium” or the “Company”) announced today that all of the nominees listed in the Management Proxy Circular dated March 28, 2013 were elected as directors of Atrium by a majority of the votes cast by the shareholders present or represented by proxy. The detailed results of the vote for the election of the directors at Atrium’s Annual General Meeting of Shareholders held earlier today in Montreal are set out below.
About Atrium Innovations
Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries. The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,100 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available at www.atrium-innovations.com.
Investor Relations:
Mario Paradis
Vice President and Chief Financial Officer
Tel. : (418) 652-1116
[email protected]
Pierre Boucher
MaisonBrison Communications
Tel. : (514) 731-0000, ext 237
[email protected]
Media Relations:
Amélie Germain
Director of Communications
Tel. : (418) 652-1116
[email protected]
- 30 -